PURPOSE To provide guidance on the clinical management of dyspnea in adult patients
with advanced cancer. METHODS ASCO convened an Expert Panel to review the evidence …

The current opioid crisis has brought renewed attention and scrutiny to opioid prescriptions.
When patients receiving opioid therapy for pain engage in nonmedical opioid use (NMOU) …

Novel synthetic opioids (NSO) are an emerging class belonging to new psychoactive
substances (NPS). They include fentanyl (eg, acetylfentanyl, ocfentanil, carfentanil …

Importance One of the main aims of research on nonmedical opioid use (NMOU) is to
reduce the frequency of NMOU behaviors through interventions such as universal …

Breathlessness, dyspnoea and shortness of breath are synonymous terms to describe the
'subjective experience of breathing discomfort that consists of qualitatively distinct …

Objective This study aimed to explore the effects of lidocaine on postoperative quality of
recovery (QoR) and immune function in patients undergoing laparoscopic radical …

Introduction Nonmedical opioid use (NMOU) in patients with cancer is a term covering a
spectrum of nonprescribed opioid use. The extent to which an individual uses opioids in a …

Buprenorphine (BUP) can be a safe and effective alternative to traditional opioids for many
patients with chronic pain. For patients on higher doses of opioids, rotation to BUP is …

The use of morphine as a first-line agent for moderate-to-severe pain is limited by the
development of analgesic tolerance. Initially opioid receptor desensitization in response to …

Use of short-acting opioids in the management of breathlessn... : Current Opinion in Supportive
and Palliative Care Use of short-acting opioids in the management of breathlessness: an …